AIM ImmunoTech Inc.: AIM ImmunoTech Reports Positive Safety,

Intranasal administration of Ampligen demonstrated to be well-tolerated Based on data generated to date, Ampligen could have potential as a prophylactic or early treatment against respiratory viral

Related Keywords

Netherlands , United Kingdom , Argentina , British , Davidr Strayer , Thomask Equels , , Linkedin , Company On Twitter , Immunotech Inc , British Society For Immunology Congress , Facebook , Early Access Program , Netherlands At Erasmus Medical Center , British Society , Immunology Congress , Executive Officer Thomas , Medical Officer , Western Equine Encephalitis Virus , Vaccinia Virus , Erasmus Medical Center , Private Securities Litigation Reform Act , Immunotech , Reports , Positive , Safety , Tolerability , Biological , Activity , Data , Intranasal , Ampligen , Intatolimod , Healthy , Subjects ,